What is Oramed Pharmaceuticals Inc.'s Market Cap?

Oramed Pharmaceuticals Inc.'s Market Cap is $207.2M, based on as-reported figures from SEC (XBRL) filings.

What is Oramed Pharmaceuticals Inc.'s Trailing P/E?

Oramed Pharmaceuticals Inc.'s Trailing P/E is 1.9×, based on as-reported figures from SEC (XBRL) filings.

What is Oramed Pharmaceuticals Inc.'s Revenue (TTM)?

Oramed Pharmaceuticals Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Oramed Pharmaceuticals Inc.'s Net Income (TTM)?

Oramed Pharmaceuticals Inc.'s Net Income (TTM) is $110.0M, based on as-reported figures from SEC (XBRL) filings.

What is Oramed Pharmaceuticals Inc.'s EBITDA?

Oramed Pharmaceuticals Inc.'s EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.

What is Oramed Pharmaceuticals Inc.'s Diluted EPS (TTM)?

Oramed Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.64, based on as-reported figures from SEC (XBRL) filings.

Oramed Pharmaceuticals Inc. (ORMP) Financial Statements

Oramed Pharmaceuticals Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SK4M90

XNAS · usd

4.98▼ 0.03 (-0.60%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close5.01

Day's Range4.92 – 5.01

52-Week Range2.09 – 5.47

Volume117.9K

Avg Volume211.1K

Share Statistics

Shares Outstanding

Employees13

ExchangeXNAS

Listed2004-04-19

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Oramed Pharmaceuticals Inc. (ORMP)

What is Oramed Pharmaceuticals Inc.'s Market Cap?: Oramed Pharmaceuticals Inc.'s Market Cap is $207.2M, based on as-reported figures from SEC (XBRL) filings.
What is Oramed Pharmaceuticals Inc.'s Trailing P/E?: Oramed Pharmaceuticals Inc.'s Trailing P/E is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Oramed Pharmaceuticals Inc.'s Revenue (TTM)?: Oramed Pharmaceuticals Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Oramed Pharmaceuticals Inc.'s Net Income (TTM)?: Oramed Pharmaceuticals Inc.'s Net Income (TTM) is $110.0M, based on as-reported figures from SEC (XBRL) filings.
What is Oramed Pharmaceuticals Inc.'s EBITDA?: Oramed Pharmaceuticals Inc.'s EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.
What is Oramed Pharmaceuticals Inc.'s Diluted EPS (TTM)?: Oramed Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.64, based on as-reported figures from SEC (XBRL) filings.